[Congressional Record (Bound Edition), Volume 162 (2016), Part 4]
[House]
[Page 5721]
[From the U.S. Government Publishing Office, www.gpo.gov]




                     EXECUTIVE COMMUNICATIONS, ETC.

   Under clause 2 of rule XIV, executive communications were taken from 
the Speaker's table and referred as follows:

       5322. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's direct final rule -- 
     Standard Preparations, Limits of Potency, and Dating Period 
     Limitations for Biological Products [Docket No.: FDA-2016-N-
     1170] received May 10, 2016, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     to the Committee on Energy and Commerce.
       5323. A letter from the Director, Regulations Policy and 
     Management Staff, FDA, Department of Health and Human 
     Services, transmitting the Department's final rule -- 
     Standards for the Growing, Harvesting, Packing, and Holding 
     of Produce for Human Consumption; Technical Amendment [Docket 
     No.: FDA-2011-N-0921] (RIN: 0910-AG35) received May 9, 2016, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       5324. A letter from the Deputy Assistant Administrator, 
     Office of Diversion Control, Drug Enforcement Administration, 
     Department of Justice, transmitting the Department's final 
     order -- Schedules of Controlled Substances: Temporary 
     Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl 
     into Schedule I [Docket No.: DEA-434F] received May 10, 2016, 
     pursuant to 5 U.S.C. 801(a)(1)(A); Public Law 104-121, Sec. 
     251; (110 Stat. 868); to the Committee on Energy and 
     Commerce.
       5325. A letter from the Deputy Assistant Administrator, 
     Office of Diversion Control, Drug Enforcement Administration, 
     Department of Justice, transmitting the Department's interim 
     final rule -- Schedules of Controlled Substances: Placement 
     of Brivaracetam into Schedule V [Docket No.: DEA-435] 
     received May 10, 2016, pursuant to 5 U.S.C. 801(a)(1)(A); 
     Public Law 104-121, Sec. 251; (110 Stat. 868); to the 
     Committee on Energy and Commerce.
       5326. A letter from the Secretary, Department of the 
     Treasury, transmitting a six-month periodic report on the 
     national emergency with respect to Sudan that was declared in 
     Executive Order 13067 of November 3, 1997, pursuant to 50 
     U.S.C. 1641(c); Public Law 94-412, Sec. 401(c); (90 Stat. 
     1257) and 50 U.S.C. 1703(c); Public Law 95-223, Sec 204(c); 
     (91 Stat. 1627); to the Committee on Foreign Affairs.
       5327. A letter from the Assistant Secretary, Legislative 
     Affairs, Department of State, transmitting a report to 
     Congress on the status of the Government of Cuba's compliance 
     with the United States-Cuba September 1994 ``Joint 
     Communique'' and the treatment by the Government of Cuba of 
     persons returned to Cuba in accordance with the United 
     States-Cuba May 1995 ``Joint Statement'', together known as 
     the Migration Accords, pursuant to Public Law 105-277, Sec. 
     2245; (112 Stat. 2681-824); to the Committee on Foreign 
     Affairs.
       5328. A letter from the Assistant Attorney General, Office 
     of Legislative Affairs, Department of Justice, transmitting 
     the FY 2015 No FEAR Act report, pursuant to Public Law 107-
     174, 203(a); (116 Stat. 569); to the Committee on Oversight 
     and Government Reform.
       5329. A letter from the Regulations Coordinator, Centers 
     for Medicare and Medicaid Services, Department of Health and 
     Human Services, transmitting the Department's interim final 
     rule -- Patient Protection and Affordable Care Act; 
     Amendments to Special Enrollment Periods and the Consumer 
     Operated and Oriented Plan Program [CMS-9933-IFC] (RIN: 0938-
     AS87) received May 10, 2016, pursuant to 5 U.S.C. 
     801(a)(1)(A); Public Law 104-121, Sec. 251; (110 Stat. 868); 
     jointly to the Committees on Energy and Commerce and Ways and 
     Means.

                          ____________________